Recovery of Candida dubliniensis from non-human immunodeficiency virus- infected patients in Israel

Journal of Clinical Microbiology

Volumn 38, Issue 1, 2000, Pages 170-174

  Polacheck, Itzhack ^a   Strahilevitz, Jacob ^a   Sullivan, Derek ^b   Donnelly, Samantha ^b   Salkin, Ira F ^c   Coleman, David C ^b  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b TRINITY COLLEGE DUBLIN   (Ireland)

^c WADSWORTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; FLUCONAZOLE;

ADULT; ARTICLE; CANDIDA DUBLINIENSIS; CASE REPORT; DIAGNOSTIC ACCURACY; FEMALE; FUNGUS IDENTIFICATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; ISRAEL; MALE; MYCOSIS; PHENOTYPE; PRIORITY JOURNAL; SPECIES DIFFERENCE; STRAIN DIFFERENCE;

ADULT; CANDIDA; CANDIDIASIS; CANDIDIASIS, ORAL; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HIV SERONEGATIVITY; HUMANS; ISRAEL; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MYCOLOGICAL TYPING TECHNIQUES; PHENOTYPE; POLYMERASE CHAIN REACTION; RESPIRATORY TRACT INFECTIONS; SEROTYPING;

EID: 0033987933     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Bikandi, J., R. San Millán, M. D. Moragues, G. Cebas, M. Clarke, D. C. Coleman, D. J. Sullivan, G. Quindós, and J. Pontón. 1998. Rapid identification of Candida dubliniensis by indirect immunofluorescence based on differential localization of antigens on C. dubliniensis blastospores and Candida albicans germ tubes. J. Clin. Microbiol. 36:2428-2433.
2. Boerlin, P., F. Boerlin-Petzold, C. Durussel, M. Addo, J.-L. Pagani, J.-P. Chave, and J. Bille. 1995. Cluster of atypical Candida isolates in a group of human immunodeficiency virus-positive drug users. J. Clin. Microbiol. 33: 1129-1135.
3. Boucher, H., S. Mercure, S. Montplaisir, and G. Lemay. 1996. A novel group I intron in Candida dubliniensis is homologous to a Candida albicans intron. Gene 180:189-196.
4. Clancy, C. J., and M. H. Nguyen. 1999. Correlation between in vitro susceptibility determined by E-test and response to therapy with amphotericin B: results front a multicenter prospective study of candidemia. Antimicrob. Agents Chemother. 43:1289-1290.
5. Coleman, D. C., D. J. Sullivan, D. E. Bennett, G. P. Moran, H. J. Barry, and D. B. Shanley. 1997. Candidiasis: the emergence of a novel species, Candida dubliniensis. AIDS 11:557-567.
6. Donnelly, S. M., D. J. Sullivan, D. B. Shanley, and D. C. Coleman. 1999. Phylogenetic analysis and rapid identification of Candida dubliniensis based on analysis of ACT1 intron and exon sequences. Microbiology 145:1871-1882.
7. Elie, C. M., T. J. Lott, E. Reiss, and C. J. Morrison. 1998. Rapid identification of Candida species with species-specific DNA probes. J. Clin. Microbiol. 36:3260-3265.
8. Fell, J. 1993. Rapid identification of yeast species using three primers in a polymerase chain reaction. Mol. Mar. Biol. Biotechnol. 2:174-180.
9. Gallagher, P. J., D. E. Bennett, M. C. Henman, R. J. Russell, S. R. Flint, D. B. Shanley, and D. C. Coleman. 1992. Reduced azole susceptibility of Candida albicans from HIV-positive patients and a derivative exhibiting colony morphology variation. J. Gen. Microbiol. 138:1901-1911.
10. Jabra-Rizk, M. A., A. A. Baqui, J. I. Kelley, W. A. Falkler, W. G. Merz, and T. F. Meiller. 1999. Identification of Candida dubliniensis in a prospective study of patients in the United States. J. Clin. Microbiol. 37:321-326.
11. Joly, S., C. Pujol, M. Rysz, K. Vargas, and D. R. Soll. 1999. Development and characterization of complex DNA fingerprinting probes for the infectious yeast Candida dubliniensis. J. Clin. Microbiol. 37:1035-1044.
12. Kirkpatrick, W. R., S. G. Revankar, R. K. McAtee, J. L. Lopez-Ribot, A. W. Fothergill, D. I. McCarthy, S. E. Sanche, R. A. Cantu, M. G. Rinaldi, and T. F. Patterson. 1998. Detection of Candida dubliniensis in oropharyngeal samples from human immunodeficiency virus-infected patients in North America by primary CHROMagar Candida screening and susceptibility testing of isolates. J. Clin. Microbiol. 36:3007-3012.
13. McCullough, M., B. Ross, and P. Reade. 1995. Characterization of genetically distinct subgroup of Candida albicans strains isolated from oral cavities of patients infected with human immunodeficiency virus. J. Clin. Microbiol. 33:696-700.
14. Meis, J. F., M. Ruhnke, B. E. De Pauw, F. C. Odds, W. Siegert, and P. E. Venweij. 1999. Candida dubliniensis candidemia in patients with chemotherapy-induced neutropenia and bone marrow transplantation. Emerg. Infect. Dis. 5:150-153.
15. Moran, G. P., D. Sanglard, S. M. Donnelly, D. B. Shanley, D. J. Sullivan, and D. C. Coleman. 1998. Identification and expression of multidrug transporters responsible for fluconazole resistance in Candida dubliniensis. Antimicrob. Agents Chemother. 42:1819-1830.
16. Moran, G. P., D. J. Sullivan, M. C. Henman, C. E. McCreary, B. J. Harrington, D. B. Shanley, and D. C. Coleman. 1997. Antifungal drug susceptibilities of oral Candida dubliniensis isolates from human immunodeficiency virus (HIV)-infected and non-HIV-infected subjects and generation of stable fluconazole-resistant derivatives in vitro. Antimicrob. Agents Chemother. 41:617-623.
17. Morschauser, J., M. Ruhnke, S. Michel, and J. Hacker. 1999. Identification of CARE-2-negative Candida albicans as Candida dubliniensis. Mycoses 42: 29-32.
18. Odds, F. C., L. Van Nuffel, and G. Dams. 1998. Prevalence of Candida dubliniensis isolates in a yeast stock collection. J. Clin. Microbiol. 36:2869-2873.
19. Pfaller, M. A., S. A. Messer, S. Gee, S. Joly, C. Pujol, D. J. Sullivan, D. C. Coleman, and D. R. Soll. 1999. In vitro susceptibilities of Candida dubliniensis isolates tested against the new triazole and echinocandin antifungal agents. J. Clin. Microbiol. 37:870-872.
20. Pincus, D. H., D. C. Coleman, W. R. Pruitt, A. A. Padhye, I. F. Salkin, M. Geimer, A. Bassel, D. J. Sullivan, M. Clarke, and V. Hearn. 1999. Rapid identification of Candida dubliniensis with commercial yeast identification systems. J. Clin. Microbiol. 37:3533-3539.
21. Pinjon, E., D. Sullivan, I. Salkin, D. Shanley, and D. Coleman. 1998. Simple, inexpensive, reliable method for differentiation of Candida dubliniensis from Candida albicans. J. Clin. Microbiol. 36:2093-2095.
22. Sullivan, D., and D. Coleman. 1998. Candida dubliniensis: characteristics and identification. J. Clin. Microbiol. 36:329-334.
23. Sullivan, D., K. Haynes, J. Bille, P. Boerlin, L. Rodero, S. Lloyd, M. Henman, and D. Coleman. 1997. Widespread geographic distribution of oral Candida dubliniensis strains in human immunodeficiency virus-infected individuals. J. Clin. Microbiol. 35:960-964.
24. Sullivan, D. J., G. Moran, S. Donnelly, S. Gee, E. Pinjon, B. McCarton, D. B. Shanley, and D. C. Coleman. 1999. Candida dubliniensis: an update. Rev. Iberoam. Micol. 16:72-76.
25. Sullivan, D. J., T. J. Westerneng, K. A. Haynes, D. E. Bennett, and D. C. Coleman. 1995. Candida dubliniensis sp. nov.: phenotypic and molecular characterisation of a novel species associated with oral candidosis in HIV-infected individuals. Microbiology 141:1507-1521.
26. Velegraki, A., and M. Logotheti. 1998. Presumptive identification of an emerging yeast pathogen: Candida dubliniensis (sp. nov.) reduces 2,3,5-triphenyltetrazolium chloride. FEMS Immunol. Med. Microbiol. 20:239-241.